Synthesis and antiarrhythmic activity of alpha-[(diarylmethoxy)methyl]-1-piperidineethanols. 1991

M L Hoefle, and L T Blouin, and R W Fleming, and S Hastings, and J M Hinkley, and T E Mertz, and T J Steffe, and C S Stratton, and L M Werbel
Parke-Davis Pharmaceutical Research Division, Warner-Lambert Company, Ann Arbor, Michigan 48105.

A series of alpha-[(diarylmethoxy)methyl]-1-piperidineethanols was evaluated for antiarrhythmic activity in the coronary artery ligated dog model. Structure-activity relationship studies indicated that the 2,6-dimethylpiperidine group afforded the best antiarrhythmic agents in this series and was essential for long duration of action. This investigation indicated that quaternary ammonium salts were not essential for a long duration of action. It was also shown that the antiarrhythmic activity could be separated from the tachycardia frequently caused by this type of agent.

UI MeSH Term Description Entries
D010880 Piperidines A family of hexahydropyridines.
D003331 Coronary Vessels The veins and arteries of the HEART. Coronary Arteries,Sinus Node Artery,Coronary Veins,Arteries, Coronary,Arteries, Sinus Node,Artery, Coronary,Artery, Sinus Node,Coronary Artery,Coronary Vein,Coronary Vessel,Sinus Node Arteries,Vein, Coronary,Veins, Coronary,Vessel, Coronary,Vessels, Coronary
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D006339 Heart Rate The number of times the HEART VENTRICLES contract per unit of time, usually per minute. Cardiac Rate,Chronotropism, Cardiac,Heart Rate Control,Heartbeat,Pulse Rate,Cardiac Chronotropy,Cardiac Chronotropism,Cardiac Rates,Chronotropy, Cardiac,Control, Heart Rate,Heart Rates,Heartbeats,Pulse Rates,Rate Control, Heart,Rate, Cardiac,Rate, Heart,Rate, Pulse
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000889 Anti-Arrhythmia Agents Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. Anti-Arrhythmia Agent,Anti-Arrhythmia Drug,Anti-Arrhythmic,Antiarrhythmia Agent,Antiarrhythmia Drug,Antiarrhythmic Drug,Antifibrillatory Agent,Antifibrillatory Agents,Cardiac Depressant,Cardiac Depressants,Myocardial Depressant,Myocardial Depressants,Anti-Arrhythmia Drugs,Anti-Arrhythmics,Antiarrhythmia Agents,Antiarrhythmia Drugs,Antiarrhythmic Drugs,Agent, Anti-Arrhythmia,Agent, Antiarrhythmia,Agent, Antifibrillatory,Agents, Anti-Arrhythmia,Agents, Antiarrhythmia,Agents, Antifibrillatory,Anti Arrhythmia Agent,Anti Arrhythmia Agents,Anti Arrhythmia Drug,Anti Arrhythmia Drugs,Anti Arrhythmic,Anti Arrhythmics,Depressant, Cardiac,Depressant, Myocardial,Depressants, Cardiac,Depressants, Myocardial,Drug, Anti-Arrhythmia,Drug, Antiarrhythmia,Drug, Antiarrhythmic,Drugs, Anti-Arrhythmia,Drugs, Antiarrhythmia,Drugs, Antiarrhythmic
D001593 Benzyl Compounds Benzene derivatives that contain a benzyl group with the general formula Phenyl-CH2-R. Compounds, Benzyl
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular

Related Publications

M L Hoefle, and L T Blouin, and R W Fleming, and S Hastings, and J M Hinkley, and T E Mertz, and T J Steffe, and C S Stratton, and L M Werbel
October 1980, Journal of medicinal chemistry,
M L Hoefle, and L T Blouin, and R W Fleming, and S Hastings, and J M Hinkley, and T E Mertz, and T J Steffe, and C S Stratton, and L M Werbel
September 1968, Arzneimittel-Forschung,
M L Hoefle, and L T Blouin, and R W Fleming, and S Hastings, and J M Hinkley, and T E Mertz, and T J Steffe, and C S Stratton, and L M Werbel
April 2002, Journal of medicinal chemistry,
M L Hoefle, and L T Blouin, and R W Fleming, and S Hastings, and J M Hinkley, and T E Mertz, and T J Steffe, and C S Stratton, and L M Werbel
June 2005, Journal of medicinal chemistry,
M L Hoefle, and L T Blouin, and R W Fleming, and S Hastings, and J M Hinkley, and T E Mertz, and T J Steffe, and C S Stratton, and L M Werbel
January 1996, Bollettino chimico farmaceutico,
M L Hoefle, and L T Blouin, and R W Fleming, and S Hastings, and J M Hinkley, and T E Mertz, and T J Steffe, and C S Stratton, and L M Werbel
January 1986, Polish journal of pharmacology and pharmacy,
M L Hoefle, and L T Blouin, and R W Fleming, and S Hastings, and J M Hinkley, and T E Mertz, and T J Steffe, and C S Stratton, and L M Werbel
July 1970, Journal of medicinal chemistry,
M L Hoefle, and L T Blouin, and R W Fleming, and S Hastings, and J M Hinkley, and T E Mertz, and T J Steffe, and C S Stratton, and L M Werbel
January 1965, Antimicrobial agents and chemotherapy,
M L Hoefle, and L T Blouin, and R W Fleming, and S Hastings, and J M Hinkley, and T E Mertz, and T J Steffe, and C S Stratton, and L M Werbel
January 1984, Acta pharmaceutica Suecica,
M L Hoefle, and L T Blouin, and R W Fleming, and S Hastings, and J M Hinkley, and T E Mertz, and T J Steffe, and C S Stratton, and L M Werbel
November 1992, Journal of medicinal chemistry,
Copied contents to your clipboard!